Episode: 035: MAPS to Move Ahead with Phase 3 MDMA Trials


Entheogen Logo
Subscribe
035: MAPS to Move Ahead with Phase 3 MDMA Trials

F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients – NY Times, Nov 29, 2016

“It changed my life.”

It allowed me to see my trauma without fear or hesitation and finally process things and move forward." – study participant Ed Thompson

“There is now a clear path ahead to make MDMA a legal medicine for millions of people suffering from PTSD.” – MAPS Bulletin

MAPS needs to raise approximately $25-30 million (of which they’ve already raised more than $10 million) to complete these Phase 3 trials and all associated toxicity and pharmacology studies over the next 5 years. – NY Times

MAPS.org



Entheogen
Users who viewed this episode also viewed...

Entheogen > 032: On the way to Burning Man 2016

I'm posting this while literally on the road to Burning Man. Enjoy the tease! We're planning to interview Rick Doblin, Alex Grey, and Allyson Grey at Burning Man! Sign up for our newsletter for the latest updates. See you in the dust!

Entheogen > 036: Dr. Jami – Broaching Psychedelics with the Uninformed

This is Entheogen. Talk about tools for generating the divine within. Today is October 23rd, 2016, and we are talking with, Dr. Jami, a psychologist in the Bay Area of California. Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode...

Entheogen > 038: Interview with Alasdair from Bluelight.org

This is Entheogen. Talk about tools for generating the divine within. Today is December 4, 2016, and we are talking with Alisdair from BlueLight.org. Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.